Michelle Stewart

5.4k total citations · 1 hit paper
38 papers, 1.2k citations indexed

About

Michelle Stewart is a scholar working on Molecular Biology, Nephrology and Genetics. According to data from OpenAlex, Michelle Stewart has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 6 papers in Nephrology and 6 papers in Genetics. Recurrent topics in Michelle Stewart's work include Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers), Parathyroid Disorders and Treatments (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Michelle Stewart is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers), Parathyroid Disorders and Treatments (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Michelle Stewart collaborates with scholars based in United States, United Kingdom and Germany. Michelle Stewart's co-authors include Leslie Amass, Márcia Waddington‐Cruz, David Forbes, David Austin, Jane McGillivray, Shari Fallet, Markay Hopps, John A. Carter, Marc Botteman and Hartmut Schmidt and has published in prestigious journals such as PLoS ONE, Human Molecular Genetics and Developmental Biology.

In The Last Decade

Michelle Stewart

37 papers receiving 1.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Does age matter? The impact of rodent age on study outcomes

2016 249 citations Michelle Stewart et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle Stewart United States	16	682	169	149	135	132	38	1.2k
Sangwon V. Kim United States	13	558 0.8×	254 1.5×	43 0.3×	118 0.9×	217 1.6×	29	2.0k
Sandra Leistner‐Segal Brazil	22	276 0.4×	190 1.1×	161 1.1×	583 4.3×	99 0.8×	88	1.6k
Kaori Adachi Japan	16	350 0.5×	129 0.8×	44 0.3×	178 1.3×	33 0.3×	57	910
Jen C. Wang United States	29	1.3k 1.9×	482 2.9×	119 0.8×	544 4.0×	119 0.9×	146	2.9k
Mauro Giorgi Italy	24	974 1.4×	196 1.2×	50 0.3×	281 2.1×	62 0.5×	79	2.1k
Mária Judit Molnár Hungary	24	992 1.5×	262 1.6×	31 0.2×	220 1.6×	61 0.5×	142	1.9k
Roberto Colombo Italy	16	315 0.5×	154 0.9×	66 0.4×	64 0.5×	37 0.3×	35	981
Frank R. Brown United States	25	1.0k 1.5×	388 2.3×	54 0.4×	296 2.2×	240 1.8×	50	1.9k
Belén Pérez‐Dueñas Spain	28	847 1.2×	334 2.0×	34 0.2×	349 2.6×	69 0.5×	109	2.0k
Jennifer Bain United States	20	767 1.1×	103 0.6×	39 0.3×	50 0.4×	73 0.6×	56	1.4k

Countries citing papers authored by Michelle Stewart

Since Specialization

Citations

This map shows the geographic impact of Michelle Stewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Stewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Stewart more than expected).

Fields of papers citing papers by Michelle Stewart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Stewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Stewart. The network helps show where Michelle Stewart may publish in the future.

Co-authorship network of co-authors of Michelle Stewart

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Stewart. A scholar is included among the top collaborators of Michelle Stewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Stewart. Michelle Stewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kooblall, Kreepa, Mark Stevenson, Raphael Heilig, et al.. (2024). Identification of cellular retinoic acid binding protein 2 (CRABP2) as downstream target of nuclear factor I/X (NFIX): implications for skeletal dysplasia syndromes. JBMR Plus. 8(7). ziae060–ziae060. 1 indexed citations

Luís, Tiago C., et al.. (2023). A method for TAT-Cre recombinase-mediated floxed allele modification in ex vivo tissue slices. Disease Models & Mechanisms. 16(11). 3 indexed citations

Sperry, Brett W., Mazen Hanna, Mathew S. Maurer, et al.. (2023). Association of Tafamidis With Health Status in Patients With ATTR Cardiac Amyloidosis. JAMA Cardiology. 8(3). 275–275. 12 indexed citations

Stewart, Michelle, Gemma Codner, Steffen Mayerl, et al.. (2022). An animal model for Pierpont syndrome: a mouse bearing the Tbl1xr1 Y446C/Y446C mutation. Human Molecular Genetics. 31(17). 2951–2963. 8 indexed citations

Rozenbaum, Mark H., Rahul Bhambri, Michelle Stewart, et al.. (2021). Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy. Journal of Comparative Effectiveness Research. 10(11). 927–938. 13 indexed citations

Rozenbaum, Mark H., Rahul Bhambri, Michelle Stewart, et al.. (2021). Impact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature Review. Cardiology and Therapy. 10(1). 141–159. 67 indexed citations

Herbert, Eleanor, Michelle Stewart, Marie Hutchison, et al.. (2020). The occurrence of tarsal injuries in male mice of C57BL/6N substrains in multiple international mouse facilities. PLoS ONE. 15(6). e0230162–e0230162.

Samjoo, Imtiaz A., et al.. (2020). The impact of clinical heterogeneity on conducting network meta-analyses in transthyretin amyloidosis with polyneuropathy. Current Medical Research and Opinion. 36(5). 799–808. 4 indexed citations

Merlini, Giampaolo, et al.. (2020). Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years. Neurology and Therapy. 9(1). 105–115. 17 indexed citations

10.

Waddington‐Cruz, Márcia, Hartmut Schmidt, Marc Botteman, et al.. (2019). Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series. Orphanet Journal of Rare Diseases. 14(1). 42 indexed citations

11.

Schnabel, Alexandra, George J. Youssef, David John Hallford, et al.. (2019). Psychopathology in parents of children with autism spectrum disorder: A systematic review and meta-analysis of prevalence. Autism. 24(1). 26–40. 119 indexed citations

12.

Schmidt, Hartmut, Márcia Waddington‐Cruz, Marc Botteman, et al.. (2016). Global Prevalence Estimates of Transthyretin Familial Amyloid Polyneuropathy (ATTR-FAP): A Systematic Review and Projections. Value in Health. 19(7). A601–A601. 1 indexed citations

13.

Stewart, Michelle, Jane McGillivray, David Forbes, & David Austin. (2016). Parenting a child with an autism spectrum disorder: a review of parent mental health and its relationship to a trauma-based conceptualisation. Advances in Mental Health. 15(1). 4–14. 17 indexed citations

14.

Alvir, José, Michelle Stewart, & Isabel Conceição. (2015). Latent Class Analysis to Classify Patients with Transthyretin Amyloidosis by Signs and Symptoms. Neurology and Therapy. 4(1). 11–24. 1 indexed citations

15.

Keohane, Denis, Jeffrey H. Schwartz, Balarama Gundapaneni, Michelle Stewart, & Leslie Amass. (2015). Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial. Orphanet Journal of Rare Diseases. 10(Suppl 1). P11–P11. 3 indexed citations

16.

Stewart, Michelle, Denis Keohane, Sarah P. Short, et al.. (2015). Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy. Orphanet Journal of Rare Diseases. 10(S1). 2 indexed citations

17.

Corrochano, Silvia, Maurizio Renna, Sarah Carter, et al.. (2011). α-Synuclein levels modulate Huntington's disease in mice. Human Molecular Genetics. 21(3). 485–494. 33 indexed citations

18.

Damrau, Christine, Anju Paudyal, Benjamin Reeve, et al.. (2009). Mouse hitchhiker mutants have spina bifida, dorso-ventral patterning defects and polydactyly: identification of Tulp3 as a novel negative regulator of the Sonic hedgehog pathway. Human Molecular Genetics. 18(10). 1719–1739. 79 indexed citations

19.

LeBlanc, Regan M., Toni Brown, Michelle Stewart, et al.. (2005). Synthesis and cytotoxicity of epoxide and pyrazole analogs of the combretastatins. Bioorganic & Medicinal Chemistry. 13(21). 6025–6034. 81 indexed citations

20.

Stewart, Michelle, Erik Madsen, Heather L. Handl, et al.. (2004). Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA. Bioorganic & Medicinal Chemistry Letters. 15(1). 177–180. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact